[1]
E. SINGH, “INHIBITORS OF BROMODOMAIN-4 AND CYCLOOXYGENASE-2: A REVIEW ON THE ADVANTAGEOUS EFFECT OF DUAL-TARGET APPROACH IN CANCER TREATMENT”, Int J Chem Res, vol. 7, no. 1, pp. 1–5, Jan. 2023.